Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)

Part of paid clinical trials in Little Rock, Arkansas.

Sponsor
Point Therapeutics
Study ID
NCT00086203
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Talabostat mesylate (PT-100) tablets — DRUG
  • Rituximab — DRUG

Study Details

The objective of this study is to assess the efficacy and safety of talabostat and rituximab in patients with advanced CLL who failed to respond, or have progressed following a prior response, to a fludarabine regimen.

Key Dates

Status verified
Aug 2006
Completion
Sep 30, 2007

Study Design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Locations (19)

FacilityCityStateZIPSite coordinators
University of Arkansas for Medical ScienceLittle RockArkansas72205-
Ocala Oncology CenterOcalaFlorida34474-
Gulfcoast Oncology AssociatesSt. PetersburgFlorida33705-
Indiana Oncology/Hematology ConsultantsIndianapolisIndiana46202-
Dana Farber Cancer InstituteBostonMassachusetts02115-
Hematology/Oncology Centers of the Northern RockiesBillingsMontana59101-
Nevada Cancer InstituteLas VegasNevada89135-
Queens Medical Associates, PCFresh MeadowsNew York11365-
Long Island Jewish Medical CenterNew Hyde ParkNew York11040-
NYU Medical CenterNew YorkNew York10016-
James P. Wilmot Cancer Center/University of RochesterRochesterNew York14642-
Raleigh Hematology/Oncology ClinicCaryNorth Carolina27511-
Wake Forest University Health SciencesWinston-SalemNorth Carolina27157-
Cancer Care Associates/Oklahoma CityOklahoma CityOklahoma73112-
Cancer Care Associates--TulsaTulsaOklahoma74136-
Cancer Centers of the CarolinasSenecaSouth Carolina29672-
Texas Cancer Center/AbileneAbileneTexas79606-5208-
MD Anderson Cancer CenterHoustonTexas77030-
Virginia Oncology Associates-Lake Wright Cancer CenterNorfolkVirginia23502-

Find similar trials in Little Rock, AR

By condition
Leukemia (other)
By specialty
OncologyBlood cancer
By research site
University of Arkansas for Medical Science· Little Rock, AROcala Oncology Center· Ocala, FLGulfcoast Oncology Associates· St. Petersburg, FLIndiana Oncology/Hematology Consultants· Indianapolis, INDana Farber Cancer Institute· Boston, MAHematology/Oncology Centers of the Northern Rockies· Billings, MT

Related Studies